On August 20, Praxis Precision Medicines, Inc. rose 5.15% in regular trading, trading at $389.76/share, with Turnover of $114 million.
Within the Biotechnology sector where Praxis Precision Medicines, Inc. belongs, the overall sector showed broad strength. Among individual stocks, Moderna, Inc. up 153.01%, BioNTech SE up 20.21%, Amgen up 4.07%, Gilead Sciences up 3.60%, AbbVie up 2.95%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)